Mostafa Faisal: Eltrombopag and Cyclosporine A for the Treatment of Moderate Aplastic Anemia
Mostafa Faisal, Associate Professor of Clinical Hematology and HSCT at Assiut University, shared a post on X about a recent article by Britta Höchsmann et al., published in Blood, adding:
“Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial.”
Title: Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial
Authors: Britta Höchsmann, Philippe Schafhausen, Fabian Beier, Michael Heuser, Jörg Westermann, Beatrice Drexler, Alexander Röth, Regina Theresia Herbst, Mathias Hänel, Michaela Schwarz, Flore Sicre de Fontbrune, Regis Peffault de Latour, Astrid Marx-Hofmann, Antonia Beitzen-Heineke, Jens P. Panse, Felicitas R Thol, Sixten Körper, Tim H. Brümmendorf, Hubert Schrezenmeier
Other posts featuring Mostafa Faisal on Hemostasis Today.
-
Aug 20, 2026, 19:46Haseeb Raza: A Practical Guide to Managing Bleeding on Anticoagulant Therapy
-
Aug 20, 2026, 19:44Harshi Peiris: 2026 Cholesterol Guidelines Bring Earlier and More Precise Risk Assessment
-
Aug 20, 2026, 18:54CDC’s Sickle Cell Data Collection Program Provides Key Insights Into Patient Care – ASH
-
Aug 20, 2026, 18:43Insights on Low Platelet Count from Anshul Gupta – Aastha Hospice
-
Aug 20, 2026, 18:15Rishabh Jain: MPNs May Finally Be Moving from Disease Control to Clonal Eradication
-
Aug 20, 2026, 18:01Ahmed Abdulrahman Al Mathehaji: LMWH Is Preferred Despite Elevated INR in Decompensated Cirrhosis
-
Aug 20, 2026, 17:43Moazzam Shahzad: Haplo-HCT With PTCy Offers a Robust Alternative to MSD-HCT
-
Aug 20, 2026, 17:04Celebrating the 2026 ISTH Reach-the-World Fellowship Recipients – ISTH
-
Aug 20, 2026, 16:13Geraldine Walsh: Exploring Blood Components in Transfusion Today